Candriam S.C.A. Penumbra Inc Transaction History

Candriam S.C.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$220.09 - $273.15 $3.17 Million - $3.93 Million	-14,402 Reduced 47.11%	16,171 $3.61 Million
Q4 2023 Feb 14, 2024	SELL	$181.44 - $260.22 $2.6 Million - $3.73 Million	-14,319 Reduced 31.9%	30,573 $7.69 Million
Q3 2023 Nov 13, 2023	BUY	$240.69 - $338.77 $800,053 - $1.13 Million	3,324 Added 8.0%	44,892 $10.9 Million
Q2 2023 Aug 08, 2023	BUY	$271.54 - $344.06 $9.59 Million - $12.1 Million	35,312 Added 564.45%	41,568 $14.3 Million
Q1 2023 May 12, 2023	SELL	$220.43 - $278.69 $2.82 Million - $3.56 Million	-12,791 Reduced 67.15%	6,256 $1.74 Million
Q4 2022 Feb 13, 2023	BUY	$151.88 - $228.5 $2.01 Million - $3.02 Million	13,209 Added 226.26%	19,047 $4.23 Million
Q3 2022 Nov 10, 2022	BUY	$120.36 - $205.88 $702,661 - $1.2 Million	5,838 New	5,838 $1.11 Million
Q4 2020 Jan 22, 2021	SELL	$174.98 - $272.83 $874,900 - $1.36 Million	-5,000 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$185.27 - $238.73 $926,350 - $1.19 Million	5,000 New	5,000 $972,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.